About
Pharmaceuticals for GI disorders
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
0
As Collaborator
4
Total Enrollment
411
By Phase
PHASE2: 2NA: 1
By Status
COMPLETED: 4
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
Today
Hover over trial bars to see details
Recent Trials
NCT04125810Collaborator
A Study to Assess the Safety and Efficacy of Probiotic to Modulate Psychological Stress
PHASE2Completed
190 participants
Started: Sep 2, 2019 · Completed: Feb 7, 2020
NCT03569202Collaborator
Piiloset Trehalose Emulsion Eye Drop Study in Moderate or Severe Dry Eye
NACompleted
64 participants
Started: May 21, 2018 · Completed: Nov 8, 2018
NCT04229082Collaborator
Next Generation Probiotics (NGPs) for Metabolic Health
N/ACompleted
100 participants
Started: Apr 8, 2016 · Completed: Jun 9, 2017
NCT01690676Collaborator
Effect of an Apple Polyphenol Extract on Brachial Artery Flow-mediated Vasodilatory Function
PHASE2Completed
57 participants
Started: Aug 31, 2012 · Completed: May 31, 2013
Locations (1)
Headquarters
Liestal, Switzerland
Map
Loading map...